Skip to main content
. 2021 May 5;8(1):e000472. doi: 10.1136/lupus-2020-000472

Figure 1.

Figure 1

Management in the clinical pathway. APS, antiphospholipid syndrome; AZA, azathioprine; CsA, ciclosporin A; CYC, cyclophosphamide; DOACS, direct oral anticoagulants; HCQ, hydroxychloroquine; LMWH, low-molecular-weight heparin; MMF, mycophenolate mofetil; MTX, methotrexate.